AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Uzan, A Jolly, D Berger, E Diebold, MD Geoffroy, P Renard, P Vandromme, L Bourgeois, L Ramaholimihaso, F Bouche, O Zeitoun, P Cadiot, G Thiefin, G
Citation: A. Uzan et al., Protective effect of appendectomy on the development of ulcerative colitis. A case-control study, GASTRO CL B, 25(3), 2001, pp. 239-242

Authors: Andre, T Colin, P Louvet, C Gamelin, E Bouche, O Achille, E Colbert, N Boaziz, C Piedbois, P Tubiana-Mathieu, N Boutan-Laroze, A Flesch, M Billiau, V Buyse, M de Gramont, A
Citation: T. Andre et al., Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminarysafety results, SEMIN ONCOL, 28(1), 2001, pp. 35-40

Authors: Giovannini, M Bardou, VJ Barclay, R Palazzo, L Roseau, G Helbert, T Burtin, P Bouche, O Pujol, B Favre, O
Citation: M. Giovannini et al., Anal carcinoma: Prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study, ENDOSCOPY, 33(3), 2001, pp. 231-236

Authors: Da Costa, N Cadiot, G Merle, C Jolly, D Bouche, O Thiefin, G Zeitoun, P
Citation: N. Da Costa et al., Bleeding reflux esophagitis: A prospective 1-year study in a university hospital, AM J GASTRO, 96(1), 2001, pp. 47-51

Authors: O'Toole, D Ducreux, M Bommelaer, G Wemeau, JL Bouche, O Catus, F Blumberg, J Ruszniewski, P
Citation: D. O'Toole et al., Treatment of carcinoid syndrome - A prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, andtolerance, CANCER, 88(4), 2000, pp. 770-776

Authors: Savry, C Bouche, O Lefrant, JY Saissy, G Allain, P
Citation: C. Savry et al., Barium sulphate poisoning?, ANN FR A R, 18(4), 1999, pp. 454-457

Authors: Andre, T Bensmaine, MA Louvet, C Francois, E Lucas, V Desseigne, F Beerblock, K Bouche, O Carola, E Merrouche, Y Morvan, F Dupon-Andre, G de Gramont, A
Citation: T. Andre et al., Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracilinfusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen, J CL ONCOL, 17(11), 1999, pp. 3560-3568

Authors: Barbare, JC Bedenne, L Bouche, O Cadiot, G Calais, G de Calan, L Conroy, T Ducreux, M Etienne, PL Elias, D Faivre, J Legoux, JL Maingon, P Mornex, F Nordlinger, B Ollier, JC Peiffert, D Pelletier, G Rat, P Rougier, P Ruskone-Fourmestraux, A Seitz, JF Triboulet, JP Trinchet, JC Vetter, D Ychou, M
Citation: Jc. Barbare et al., What can be done for patients with cancer of the digestive tract in 1999? Guidelines of the French Foundation of Digestive Tract Cancerology (2(nd) part), GASTRO CL B, 23(5), 1999, pp. 486-496

Authors: Barbare, JC Bedenne, L Bouche, O Cadiot, G Calais, G de Calan, L Conroy, T Ducreux, M Etienne, PL Elias, D Faivre, J Legoux, JL Maingon, P Mornex, F Nordlinger, B Ollier, JC Peiffert, D Pelletier, G Rat, P Rougier, P Ruskone-Fourmestraux, A Seitz, JF Triboulet, JP Trinchet, JC Vetter, D Ychou, M
Citation: Jc. Barbare et al., What can be done for patients with cancer of the digestive tract in 1999? Guidelines of the French Foundation of Digestive Tract Cancerology (1st part), GASTRO CL B, 23(4), 1999, pp. 502-512

Authors: Cailliez-Tomasi, JP Bouche, O Avisse, C Ramaholimihaso, F Diebold, MD Flament, JB
Citation: Jp. Cailliez-tomasi et al., Rectal leimoyosarcoma: 4 cases, GASTRO CL B, 23(4), 1999, pp. 523-527

Authors: Devulder, F Bouche, O Diebold, MD Abdelli, N Fremond, L Cambier, MP Thiefin, G
Citation: F. Devulder et al., Cronkhite-Canada's syndrome: a new French case, GASTRO CL B, 23(3), 1999, pp. 407-408

Authors: Zeitoun, P Salmon, L Bouche, O Jolly, D Thiefin, G
Citation: P. Zeitoun et al., Outcome of erosive/ulcerative reflux oesophagitis in 181 consecutive patients 5 years after diagnosis, ITAL J GAST, 30(5), 1998, pp. 470-474

Authors: Desoize, B Bouche, O Berthiot, G Coninx, P
Citation: B. Desoize et al., Puzzles in the clinical pharmacokinetics of fluorouracil, ANTICANC R, 18(6B), 1998, pp. 4607-4610
Risultati: 1-13 |